MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Gastro-intestinal system

K&M Inflammatory Bowel Disease (Adults) HCD Pathway

K&M PR 2022-25: Dual biological therapy for inflammatory bowel disease (IBD) in adults

 K&M ICB Position Statement – GI Anti-spasmodics: Dicycloverine and Propantheline prescribing not supported

K&M Stoma Accessories Formulary

K&M ICB Position Statement - Proton Pump Inhibitor (PPI) Oral Suspension for Adults in Primary Care

K&M ICB Position Statement - Omeprazole Oral Suspension for Paediatrics in Primary Care